(Q51014889)

27 March 2018

title

Acid active receptor-specific peptide ligand for in vivo tumor-targeted delivery (English)

1 reference

27 March 2018

author name string

Liang Han

1

1 reference

27 March 2018

Yubo Guo

2

1 reference

27 March 2018

Haojun Ma

3

1 reference

27 March 2018

Xi He

4

1 reference

27 March 2018

Yuyang Kuang

5

1 reference

27 March 2018

Ning Zhang

6

1 reference

27 March 2018

Ed Lim

7

1 reference

27 March 2018

Wenjiang Zhou

8

1 reference

27 March 2018

Chen Jiang

9

1 reference

27 March 2018

publication date

5 May 2013

1 reference

27 March 2018

published in

Small

1 reference

27 March 2018

volume

9

1 reference

27 March 2018

issue

21

1 reference

27 March 2018

page(s)

3647-3658

1 reference

27 March 2018

Targeting of Cancer Cells Using Quantum Dot-Polypeptide Hybrid Assemblies that Function as Molecular Imaging Agents and Carrier Systems

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Comparison of changes in gene expression of transferrin receptor-1 and other iron-regulatory proteins in rat liver and brain during acute-phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Integrin-regulated FAK-Src signaling in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Tumor pH and its measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Enhancement of chemotherapy by manipulation of tumour pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Super pH-sensitive multifunctional polymeric micelle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Active targeting schemes for nanoparticle systems in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Receptor mediated uptake of peptides that bind the human transferrin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Choline-derivate-modified nanoparticles for brain-targeting gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Evaluation and mechanism studies of PEGylated dendrigraft poly-L-lysines as novel gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Orthotopic models are necessary to predict therapy of transplantable tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.201300279

21 January 2018

Identifiers

DOI

10.1002/SMLL.201300279

1 reference

27 March 2018

1 reference

27 March 2018